Quiz 4? (ID, HTN, Pain) Flashcards

1
Q

What polymorphic enzyme affects opioid efficacy?

A

CYP2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the nonfunctional alleles for CYP2D6?

A

4, 5, 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What mutation makes a CYP2D6 allele have increased function?

A

More copies of *1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What population is more likely to be UM at CYP2D6?

A

African patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What populations are more likely to be poor metabolizers at CYP2D6?

A

Hispanic, African, White (not Asian)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What metabolizers (poor, intermediate, ultrarapid) should avoid use of opiates?

A

PM, UM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which opiates have a clinical recommendation based on pharmacogenomics

A

Codeine, dihydrocodeine

Not oxycodone, hydrocodone, or tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Polymorphisms in the u-opioid receptor MOR increase/decrease response to morphine?

A

Decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COMT degrades ____

A

NTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COMT homozygous ___ has ____ response to morphine

A

Met, higher (lower morphine requirements)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which ADRB1 mutation location causes loss of function: 389 or 49?

A

389

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ADRB1 389 mutation is more common in african americans or other populations?

A

African Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which ADRB1 mutation causes gain of function? 389 or 49

A

49

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do the ADRB2 mutations affect receptors?

A

downregulate them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Do the ADRB2 mutations cause loss or gain of function?

A

Loss of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What populations are more likely to have Gly16Arg mutation?

A

Asians/AAs

17
Q

What populations are more likely to have Gln 27 Glu mutation?

A

Caucasians/AAs

18
Q

ADD1 SNP causes blood pressure raising or lowering effects?

A

Lowering

19
Q

Rs145038 is found near _____

A

FGF5

20
Q

What’s the significance of FGF5?

A

Response to HCTZ and atenolol–one SNP (TT) had better response to atenolol, the other (CC) to HCTZ

21
Q

Which Cyp metabolizes efavirenz?

A

CYP2B6

22
Q

What is the etoxicity associated with poor efavirenz metabolism?

A

QT Prolongation

23
Q

How does efavirenz cause its toxicity?

A

Prolongs AP by inhibiting K repolarizing current

24
Q

What are the LOF alleles on CYp2B6?

A

*6,18

25
Q

What CYP metabolizes voriconazole?

A

2c19

26
Q

Which CYP2C19 are LOF?

A

*2/3

27
Q

Which CYp2C19 polymorphisms are GOF?

A

*17

28
Q

Choose an alternative agent for voriconazole for which populations of metabolizers? (Ultrarapid, poor, rapid, normal?)

A

UM, PM, RM

29
Q

What infectious disease meds have CPIC guidelines?

A

Abacavir
Atazanavir
Ribavirin/Peginterferon
Voriconazole

30
Q

Abacavir mutation?

A

HLA-B

31
Q

Abacavir toxicity?

A

SJS/TEN

32
Q

Atazanavir mutation?

A

UGT1A1

33
Q

Atazanavir toxicity?

A

Jaundice

34
Q

Ribavirin/Peginterferon mutation?

A

IFNL3

35
Q

Ribaviran/Peginterferon treatment? Viral genotype 1 v. viral genotype 2

A

Type 1: 48 weeks, less chance of success

Type 2: 24 weeks, higher chance of success

36
Q

IFNL3 mutation affects what system?

A

JAK-STAT, immune system modulating

37
Q

IFNL3 polymorphism (T) reduces/increases chance of success?

A

Reduces success

38
Q

CCR5 affects what disease?

A

HIV

39
Q

32 homozygotes are more/less resistant to R5 HIV?

A

More resistant